Fields »
ABOUT
HELP
BLOG

374 GENES FOUND

Show / hide columns »

XML | RDF | TAB | « prev | Page of 8 | next »

Gene

 

 

Gene description

x

 

 

Protein class

x

 

 

 

 

Tissue

Cell

Cancer

 

 

 

 

 

 

Subcellular location

x

RNA tissue category

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 
IL13RA1Interleukin 13 receptor, alpha 1CD markers
Predicted membrane proteins
Predicted secreted proteins
Nucleoplasm
Golgi apparatus		Expressed in all
IL13RA2Interleukin 13 receptor, alpha 2Cancer-related genes
CD markers
Predicted membrane proteins
Nucleus
Nucleoli		Tissue enriched
IL15RAInterleukin 15 receptor, alphaCD markers
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membrane
Cytosol		Expressed in all
IL17RAInterleukin 17 receptor ACD markers
Disease related genes
Predicted membrane proteins
Predicted secreted proteins
Nucleoplasm
Cytosol		Mixed
IL18R1Interleukin 18 receptor 1CD markers
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
MitochondriaMixed
IL18RAPInterleukin 18 receptor accessory proteinCD markers
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
IL1R1Interleukin 1 receptor, type ICancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
VesiclesExpressed in all
IL1R2Interleukin 1 receptor, type IICancer-related genes
CD markers
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Mixed
IL21RInterleukin 21 receptorCancer-related genes
CD markers
Disease related genes
Predicted membrane proteins
Plasma membrane
Cytosol		Tissue enhanced
IL2RAInterleukin 2 receptor, alphaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
IL2RBInterleukin 2 receptor, betaCancer-related genes
CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
IL2RGInterleukin 2 receptor, gammaCancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
VesiclesTissue enhanced
IL3RAInterleukin 3 receptor, alpha (low affinity)CD markers
FDA approved drug targets
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IL4RInterleukin 4 receptorCancer-related genes
CD markers
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
CytosolExpressed in all
IL5RAInterleukin 5 receptor, alphaCD markers
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
IL6RInterleukin 6 receptorCancer-related genes
Candidate cardiovascular disease genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Expressed in all
IL6STInterleukin 6 signal transducerCancer-related genes
Candidate cardiovascular disease genes
CD markers
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Plasma membrane		Expressed in all
IL7RInterleukin 7 receptorCancer-related genes
CD markers
Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Plasma membraneExpressed in all
IL9RInterleukin 9 receptorCD markers
Predicted membrane proteins
Tissue enhanced
INSRInsulin receptorCD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
RAS pathway related proteins
VesiclesExpressed in all
ITGA1Integrin, alpha 1Cancer-related genes
CD markers
Plasma proteins
Predicted membrane proteins
Transporters
Endoplasmic reticulumMixed
ITGA2Integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)Cancer-related genes
CD markers
Plasma proteins
Predicted membrane proteins
Nucleus
Cytosol		Mixed
ITGA2BIntegrin, alpha 2b (platelet glycoprotein IIb of IIb/IIIa complex, antigen CD41)Cancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Cell Junctions
Cytosol		Tissue enhanced
ITGA3Integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)Cancer-related genes
CD markers
Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneMixed
ITGA4Integrin, alpha 4 (antigen CD49D, alpha 4 subunit of VLA-4 receptor)Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Golgi apparatus
Vesicles		Tissue enhanced
ITGA5Integrin, alpha 5 (fibronectin receptor, alpha polypeptide)Cancer-related genes
CD markers
Plasma proteins
Predicted membrane proteins
Expressed in all
ITGA6Integrin, alpha 6Cancer-related genes
CD markers
Disease related genes
Plasma proteins
Potential drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Expressed in all
ITGADIntegrin, alpha DCD markers
Predicted membrane proteins
Tissue enriched
ITGAEIntegrin, alpha E (antigen CD103, human mucosal lymphocyte antigen 1; alpha polypeptide)CD markers
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
ITGALIntegrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ITGAMIntegrin, alpha M (complement component 3 receptor 3 subunit)Cancer-related genes
CD markers
Disease related genes
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
ITGAVIntegrin, alpha VCancer-related genes
CD markers
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Focal adhesion sites
Cytosol		Expressed in all
ITGAXIntegrin, alpha X (complement component 3 receptor 4 subunit)CD markers
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ITGB1Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)Cancer-related genes
CD markers
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Endoplasmic reticulum
Plasma membrane
Focal adhesion sites		Expressed in all
ITGB2Integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)CD markers
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
CytosolExpressed in all
ITGB3Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)Cancer-related genes
CD markers
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
ITGB4Integrin, beta 4Cancer-related genes
CD markers
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleus
Plasma membrane
Cell Junctions		Mixed
JAG1Jagged 1CD markers
Disease related genes
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Golgi apparatus
Plasma membrane		Expressed in all
JAM2Junctional adhesion molecule 2CD markers
Predicted membrane proteins
CytosolTissue enhanced
KDRKinase insert domain receptorCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Plasma membraneTissue enhanced
KELKell blood group, metallo-endopeptidaseBlood group antigen proteins
Cancer-related genes
CD markers
Enzymes
Predicted membrane proteins
Tissue enhanced
KIR2DL1Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1CD markers
Predicted membrane proteins
Not detected
KIR2DL3Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3CD markers
Predicted membrane proteins
Not detected
KIR2DL4Killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 4CD markers
Predicted membrane proteins
Predicted secreted proteins
Not detected
KIR3DL1Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1CD markers
Predicted membrane proteins
Not detected
KIR3DL2Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2CD markers
Predicted membrane proteins
Not detected
KITV-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homologCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Plasma membraneTissue enhanced
KLRB1Killer cell lectin-like receptor subfamily B, member 1CD markers
Predicted membrane proteins
Nucleoplasm
Cytosol		Mixed
KLRC1Killer cell lectin-like receptor subfamily C, member 1CD markers
Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneMixed
KLRC2Killer cell lectin-like receptor subfamily C, member 2CD markers
Predicted intracellular proteins
Predicted membrane proteins
Plasma membraneGroup enriched

« prev | Page of 8 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.